Advancement in benzoyl peroxide-based acne treatment: Methods to increase both efficacy and tolerability

Journal of Drugs in Dermatology

Volumn 8, Issue 7, 2009, Pages 657-661

  Fakhouri, Tarek ^a   Yentzer, Brad A ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE PLUS BENZOYL PEROXIDE; ALLYLAMINE DERIVATIVE; ALPHA TOCOPHEROL; ANTIFUNGAL AGENT; BENZOYL PEROXIDE; DRUG VEHICLE; RETINOIC ACID; RETINOID; TERTIARY AMINE; UREA; ANTIINFECTIVE AGENT; DERMATOLOGICAL AGENT;

ACNE; ACNE VULGARIS; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MEDLINE; MICROPARTICLE DELIVERY SYSTEM; MONOTHERAPY; SKIN ABSORPTION; SKIN IRRITATION; ANTIBIOTIC RESISTANCE; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROPIONIBACTERIUM ACNES; REVIEW;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; PROPIONIBACTERIUM ACNES;

EID: 67651176368     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Oberemok SS, Shalita AR. Acne vulgaris, II: Treatment. Cutis. 2002;70(2):111-114. (Pubitemid 41757463)
2. Tanghetti E. The impact and importance of resistance. Cutis. 2007;80(1 Suppl):5-9.
3. Taylor GA, Shalita AR. Benzoyl peroxide-based combination therapies for acne vulgaris: A comparative review. Am J Clin Dermatol. 2004;5(4):261-265. (Pubitemid 39127968)
4. Kligman AM, Leyden JJ, Stewart R. New uses for benzoyl peroxide: A broad-spectrum antimicrobial agent. Int J Dermatol. 1977;16(5):413-417. (Pubitemid 8142815)
5. Eady EA, Farmery MR, Ross JI, et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol. 1994;131(3):331-336. (Pubitemid 24290215)
6. Wolf R, Matz H, Parish LC. After the antibiotics and breast cancer study: What to tell patients. Skinmed. 2004;3(3):125-127.
7. Burkhart CG, Burkhart CN. Treatment of acne vulgaris without antibiotics: tertiary amine-benzoyl peroxide combination vs. benzoyl peroxide alone (Proactiv Solution). Int J Dermatol. 2007;46(1):89-93. (Pubitemid 46029733)
8. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674.
9. Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002;24(7):1117-1133. (Pubitemid 34833234)
10. Parry MF, Rha CK. Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol. 1986;122(5):583-584. (Pubitemid 16090925)
11. Milstone EB, McDonald AJ, Scholhamer CF Jr. Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol. 1981;117(3):154-155. (Pubitemid 11153914)
12. Burkhart CN, Burkhart CG. Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int J Dermatol. 2003;42(12):925-927. (Pubitemid 38004460)
13. Burkhart CN, Specht K, Neckers D. Synergistic activity of benzoyl peroxide and erythromycin. Skin Pharmacol Appl Skin Physiol. 2000;13(5):292-296. (Pubitemid 30666028)
14. Burkhart CG, Burkhart CN. Antibacterial properties of benzoyl peroxide in aerobic and anaerobic conditions. Int J Dermatol. 2006;45(11):1373-1374. (Pubitemid 44688043)
15. Rota C, Tomasi A, Iannone A. Alpha-tocopherol amplifies benzoyl peroxide free radical decomposition in a chemical system. Free Radic Res. 2006;40(6):637-645. (Pubitemid 43832519)
16. Shalita AR, Rafal ES, Anderson DN, et al. Compared efficacy and safety of tretinoin 0.1% microsphere gel alone and in combination with benzoyl peroxide 6% cleanser for the treatment of acne vulgaris. Cutis. 2003;72(2):167-172. (Pubitemid 37229749)
17. Pariser DM, Westmoreland P, Morris A, et al. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6(9):899-905.
18. Jelvehgari M, Siahi-Shadbad MR, Azarmi S, et al. The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies. Int J Pharm. 2006;308(1-2):124-132. (Pubitemid 43097243)
19. Burkhart CG, Scheinfeld NS. Benzoyl peroxide skin washes: basis, logic, effectiveness, and tolerance. Skinmed. 2005;4(6):370.
20. Mills OH Jr, Kligman AM, Pochi P, Comite H. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol. 1986;25(10):664-667. (Pubitemid 17210594)
21. Fyrand O, Jakobsen HB. Water-based versus alcohol-based benzoyl peroxide preparations in the treatment of acne vulgaris. Dermatologica. 1986;172(5):263-267. (Pubitemid 16095697)
22. Weinberg JM. The utility of benzoyl peroxide in hydrophase base (Brevoxyl) in the treatment of acne vulgaris. J Drugs Dermatol. 2006;5(4):344-349.
23. Sawleshwarkar SN, Salgaonkar V, Oberai CM. Multicenter study to evaluate efficacy and irritation potential of benzoyl peroxide 4% cream in hydrophase base (Brevoxyl) in acne vulgaris. Indian J Dermatol Venereol Leprol. 2003;69(1):19-22. (Pubitemid 44943138)
24. Gold MH. A multicenter efficacy and tolerability evaluation of benzoyl peroxide in a 10% urea vehicle for the treatment of acne vulgaris. J Drugs Dermatol. 2006;5(5):442-445.